InSights Hub

News

Showing 181 to 190 of 283 (Page 19)

Upcoming FDA Approvals & Decisions - June 2024

Upcoming FDA Decisions – June 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Read More
What's Changed - Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS) Guidelines – What’s Changed

Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease, is a neurological disorder that impacts the motor neurons responsible for controlling voluntary muscle movement and breathing, according to the National Institutes of Health (NIH). The Centers for Disease Control and Prevention (CDC) has reported that at least 16,000 Americans are affected by ALS. […]

Read More
BSH Int'l Guidelines

The British Society for Haematology – Guidelines International Series

In our first installment of our Guidelines International Series, we will be examining the British Society for Haematology (BSH). As the largest haematology organization in the United Kingdom (UK), boasting over 3,000 members worldwide, BSH is the premier membership organization for haematology professionals in the UK. BSH is dedicated to promoting excellence in the study, […]

Read More
Guidelines Rundown Multiple Sclerosis

Multiple Sclerosis – Guidelines Rundown

Our Guidelines Rundown Series continues with a new article focusing on multiple sclerosis (MS). Currently, there are limited guidelines available on MS, all of which are provided by the American Academy of Neurology. These guidelines encompass a range of topics including vaccines and immunizations, therapies, alternative medicine, as well as the assessment and management of […]

Read More
Guidelines + Trials Spotlight - Enhertu Metastatic Breast Cancer

Enhertu® Metastatic Breast Cancer Trial Results DESTINY-Breast06

According to the National Institutes of Health (NIH), around 13% of women will receive a cancer diagnosis at some stage in their lives. In 2021, an estimated 3,972,256 women were living with cancer in the United States. The most prevalent cancer subtype is HR+/HER2-, with an age-adjusted rate of 90 new cases per 100,000 women, […]

Read More
Guidelines Spotlight ACP Diabetes Guidelines

New 2024 ACP Diabetes Guidelines and the Removal of DPP4s – Guidelines Spotlight

The American College of Physicians (ACP) released a new clinical guideline on April 19, 2024, for Newer Pharmacologic Treatments in Adults With Type 2 Diabetes. This guideline focused specifically on three classes of medications commonly used for patients with Type 2 Diabetes Mellitus: While the guideline is relatively short, consisting of only three key recommendations, […]

Read More
Comparing Atopic Dermatitis Guidelines Side-By-Side

Comparing Atopic Dermatitis Guidelines – Guidelines Side-By-Side Series

For this installment of our Guidelines Side-By-Side Series, we’re going to take a look at the current guidelines for atopic dermatitis (AD), commonly referred to as eczema. It is a chronic inflammatory skin condition, identified by dry, itchy skin that may release clear fluid when scratched. The National Institutes of Health (NIH) estimates that this […]

Read More
Guidelines Rundown Tuberculosis

Tuberculosis – Guidelines Rundown

Our Guidelines Rundown Series progresses with a new article focused on tuberculosis. Numerous guidelines on tuberculosis are currently available, published by nearly a dozen different medical societies and organizations. The most recent guideline, issued by the World Health Organization, stands out as it leads the global initiative to eradicate tuberculosis by advocating for universal access […]

Read More
DDW 2024 Recap

DDW2024 Conference Recap: Crohn’s Disease and Ulcerative Colitis at Digestive Disease Week

The American Gastroenterological Association’s (AGA) annual meeting was held in Washington, DC from May 18-21, 2024. Digestive Disease Week® (DDW2024) is considered the leading event for gastroenterology professionals, featuring innovative advancements, networking opportunities, and the most recent research in the field. Today, we will explore some of the fascinating research presented at the DDW2024, with […]

Read More
« Back to InSights Hub